Sign in

You're signed outSign in or to get full access.

Holly Van Deursen

Director at ALBEMARLEALBEMARLE
Board

About Holly A. Van Deursen

Independent director (since 2019) with 25 years in chemicals, oil, and energy; former Group Vice President, Petrochemicals at BP and prior engineering/manufacturing roles at Dow Corning. Age 66; serves on Albemarle’s Executive Compensation & Talent Development and Capital Investment Committees; the Board has affirmed her independence under NYSE standards and Albemarle’s guidelines .

Past Roles

OrganizationRoleTenureCommittees/Impact
BP plcGroup Vice President, Petrochemicals; member of top-forty executive management team2000–2005Global business management and sector experience cited for ALB nomination
Dow Corning CorporationEngineering, manufacturing, product development rolesNot dated (prior to BP)Chemical/industrial operational experience

External Roles

OrganizationRoleTenureCommittees/Impact
Kimball Electronics Inc.Director2019 – currentNot disclosed
Synthomer plcDirector2018 – currentNot disclosed
Capstone Green Energy CorporationChair (2017–2020); Director2007 – 2021Governance leadership experience as Chair
Enerpac Tool Group (formerly Actuant Corporation)Director2008 – 2020Industrial sector experience

Board Governance

  • Independence: Board determined Van Deursen is independent under NYSE and Albemarle guidelines .
  • Committee assignments: Executive Compensation & Talent Development and Capital Investment; not a committee chair .
  • Attendance: Board held 7 meetings in 2024; each director attended at least 86% of Board meetings; Exec Compensation Committee held 7 meetings with each member at least 86% attendance; Capital Investment Committee held 4 meetings with 100% attendance .
  • Anti-hedging/pledging, clawbacks: Company policy prohibits director hedging and pledging; clawback policies apply to incentive compensation .
  • Share ownership guidelines: Non-employee directors must hold stock equal to 5x annual cash retainer within five years; all directors were in compliance as of March 12, 2025 .

Committee Assignments and 2024 Attendance

CommitteeRoleMeetings (2024)Attendance
Executive Compensation & Talent DevelopmentMember7Each member ≥86%
Capital InvestmentMember4Each member 100%

Fixed Compensation

Component (2024)AmountNotes
Fees Earned or Paid in Cash$120,000Annual cash retainer; Van Deursen elected to defer 100% to deferred cash account
All Other Compensation$3,000Matching gifts via Albemarle Foundation

Director Compensation Program (Structure)

ElementAmount/Terms
Annual Cash Retainer$120,000
Annual Equity Retainer$170,000 restricted stock (granted first trading day of July; vests next July 1 if term completed)
Chair Fees (if applicable)Audit $25,000; Exec Comp $20,000; N&G $15,000; Sustainability $15,000; Capital Investment $15,000
Meeting FeesNone (no per-meeting fees)
Deferred CompensationDirectors may defer cash and/or stock; phantom shares receive dividend equivalents

Performance Compensation

Equity Grant Detail (2024)DataNotes
Grant DateJuly 1, 2024Annual director grant date
Shares Granted1,750Calculated by $170,000 ÷ $97.41, rounded to next 25 shares
Grant Date Fair Value$170,468FASB ASC 718 value
VestingJuly 1, 2025 (subject to service)Standard director vesting
Deferral Election100% of stock deferred to phantom stock accountVan Deursen elected full deferral of stock
OptionsNone outstanding for non-employee directorsNo director stock options

Directors do not receive performance-based equity (no PSUs/TSR metrics) in the director program; equity is time-based restricted stock only .

Other Directorships & Interlocks

CompanySector OverlapPotential InterlockDisclosure
Kimball Electronics Inc.Contract manufacturingNone disclosedListed as current public board
Synthomer plcSpecialty polymersNone disclosedListed as current public board
Capstone Green EnergyEnergy systemsNone disclosedFormer Chair/Director
Enerpac Tool GroupDiversified industrialNone disclosedFormer Director

Compensation Committee interlocks: None. No member of Exec Comp Committee was an officer/employee; no reciprocal committee interlocks; no relationships disclosed in related-party section .

Expertise & Qualifications

  • Extensive chemical/industrial sector experience; executive roles in business management, business development, and M&A across U.S. and global markets .
  • Skills cited by ALB for nomination include sector breadth across oilfield services, diversified industrials, packaging; contributes to Executive Compensation and Capital Investment oversight .

Equity Ownership

Ownership Item (as of Mar 12, 2025)AmountNotes
Beneficially Owned Shares1,650Direct beneficial ownership
Phantom Shares (no voting/investment power)5,895Deferred stock account balance
Ownership % of Class<1%Asterisk denotes <1% of 117,650,568 shares
Pledged or HedgedProhibited by policyAnti-hedging/pledging policies for directors
Ownership Guideline5x annual cash retainerAll directors in compliance as of record date

Insider Trades

Compliance Indicator (2024)Status
Delinquent Section 16(a) ReportsNone (compliant)

Say-on-Pay & Compensation Committee Signals

  • 2024 Say-on-Pay approval: 85.9% support; signals generally favorable shareholder view despite sector headwinds .
  • Committee governance: Farient Advisors retained as independent consultant; independence confirmed by Committee under SEC/NYSE standards .
  • Pay discipline: Committee exercised negative discretion reducing 2024 annual incentive payouts by 34 percentage points enterprise-wide to align pay with underlying performance and adjust for capitalized inefficiencies; indicates rigorous oversight culture .
  • Peer group benchmarking: Chemicals/metals/mining peers maintained; methodology adjusted to reflect revenue sensitivity to lithium prices (median revenue around ~$8B complexity proxy) .

Related Party Transactions

  • None: Audit & Finance Committee reported no related person transactions since the beginning of 2024; policy requires arm’s-length terms and Committee approval thresholds .

Governance Assessment

  • Strengths: Independent director with relevant sector/M&A expertise; active service on Executive Compensation & Capital Investment Committees; solid attendance; compliance with robust stock ownership guidelines; anti-hedging/pledging and clawback policies; no related-party exposures; compensation oversight evidences negative discretion and independent consultant engagement .
  • Alignment signals: 2024 director equity fully deferred to phantom stock; reinforces long-term alignment; direct beneficial ownership plus phantom shares; guideline compliance .
  • Potential watch items: Multiple concurrent public boards (current total incl. ALB = 3 per competency summary) may require ongoing monitoring for time commitments, though no attendance issues disclosed .